RxDoctor Payments Data

Albert Dimeo, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Roslyn, NYNPI 1922080050

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $38,370 of the $55,220 with a category attached, or 69.5%. 27 manufacturers reported payments, led by Medtronic at 41.8% of the total. 2025 is the largest year on record at $25,252, 5.3 times the $4,731 reported in 2019.

$55,220in general payments, 2019–2025

Across 561 payments — averaging $98.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$23K
  • Abbott$10K
  • Edwards Lifesciences$10K
  • Atricure, Inc.$4K
  • Intuitive Surgical$2K
  • Zimmer Biomet$1K
  • plus $5K from 21 others
$58,386in research payments, 2019–2025

Across 4 payments — averaging $14,597 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$58K

What the payments were for

  • Speaking & faculty fees$3,0255%
  • Travel & lodging$13,82625%
  • Food & beverage$38,37069%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,220 in reported general payments places this provider in the 85th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024
$582,635
Medicare patients
295
Services billed
909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Roslyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →